Satellos Bioscience Inc. (MSLE) stock

MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 27, 2026Score 5/30

$6.83+0.08 (+1.19%)

Close on Nov 12, 2026Market cap $105.58MP/E –Yield –

Satellos Bioscience gross margin

Gross margin is gross profit as a percentage of revenue.

Satellos Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?